F M Investments LLC Buys Shares of 202,591 Astrana Health, Inc. (NASDAQ:ASTH)

F M Investments LLC bought a new stake in Astrana Health, Inc. (NASDAQ:ASTH - Free Report) during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor bought 202,591 shares of the company's stock, valued at approximately $11,738,000. F M Investments LLC owned about 0.36% of Astrana Health as of its most recent SEC filing.

A number of other large investors have also recently bought and sold shares of the company. SteelPeak Wealth LLC purchased a new stake in Astrana Health in the third quarter valued at approximately $39,398,000. New York State Teachers Retirement System purchased a new stake in Astrana Health in the third quarter valued at approximately $2,515,000. Nisa Investment Advisors LLC purchased a new stake in Astrana Health in the third quarter valued at approximately $35,000. State of Alaska Department of Revenue purchased a new stake in Astrana Health in the third quarter valued at approximately $1,373,000. Finally, NorthCrest Asset Manangement LLC purchased a new stake in Astrana Health in the third quarter valued at approximately $26,704,000. Hedge funds and other institutional investors own 52.77% of the company's stock.

Astrana Health Price Performance

Shares of ASTH stock traded up $0.75 during trading hours on Friday, hitting $54.53. 161,652 shares of the company's stock were exchanged, compared to its average volume of 196,519. The company has a quick ratio of 1.84, a current ratio of 1.84 and a debt-to-equity ratio of 0.62. The firm has a market cap of $2.68 billion, a P/E ratio of 37.87, a P/E/G ratio of 2.12 and a beta of 1.21. The firm has a 50 day moving average of $54.81 and a two-hundred day moving average of $46.85. Astrana Health, Inc. has a fifty-two week low of $28.86 and a fifty-two week high of $63.20.

Astrana Health (NASDAQ:ASTH - Get Free Report) last announced its earnings results on Wednesday, August 7th. The company reported $0.40 earnings per share for the quarter, topping the consensus estimate of $0.39 by $0.01. The business had revenue of $486.30 million during the quarter, compared to the consensus estimate of $440.68 million. Astrana Health had a return on equity of 10.71% and a net margin of 4.30%. The business's quarterly revenue was up 39.7% on a year-over-year basis. During the same period in the prior year, the company posted $0.28 EPS. Sell-side analysts forecast that Astrana Health, Inc. will post 1.31 EPS for the current year.

Analysts Set New Price Targets

Several equities research analysts have commented on the company. KeyCorp assumed coverage on Astrana Health in a research report on Friday, October 11th. They issued a "sector weight" rating on the stock. Truist Financial upped their price objective on Astrana Health from $50.00 to $59.00 and gave the stock a "buy" rating in a research report on Friday, August 9th. Stifel Nicolaus upped their price objective on Astrana Health from $48.00 to $60.00 and gave the stock a "buy" rating in a research report on Thursday, August 1st. Robert W. Baird upped their price objective on Astrana Health from $54.00 to $67.00 and gave the stock an "outperform" rating in a research report on Thursday, August 15th. Finally, BTIG Research upped their price objective on Astrana Health from $60.00 to $70.00 and gave the stock a "buy" rating in a research report on Thursday, October 3rd. One investment analyst has rated the stock with a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat, the stock has a consensus rating of "Buy" and an average target price of $62.00.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.